Photospectra announces opening of its website to facilitate recruitment to the Toronto and Oak Ridge Photobiomodulation study for dry Age-related Macular Degeneration (TORPA).

Patients may enroll in Oak Ridge, Tennessee, USA and Toronto, Ontario, Canada. A treatment phase site in Barrie, Ontario, Canada will be open in November 2009. For details please see CLINICAL TRIAL.